Looking ahead, life sciences companies will encounter fundraising challenges and increased competition for experienced and highly skilled talent, as well as fallout from volatile economic conditions. However, innovation and opportunity are always on the horizon for many businesses in the biopharma, life sciences services and medtech sectors. We explore what’s happening and what’s to come.
Read the report here.